{"id":35502,"date":"2022-09-21T15:23:51","date_gmt":"2022-09-21T13:23:51","guid":{"rendered":"https:\/\/www.gsk.de\/?p=35502"},"modified":"2022-09-21T15:23:52","modified_gmt":"2022-09-21T13:23:52","slug":"kaufpreiseinbehalte-beim-exit-earn-out-oder-take-the-money-and-run","status":"publish","type":"post","link":"https:\/\/gsk.de\/de\/kaufpreiseinbehalte-beim-exit-earn-out-oder-take-the-money-and-run\/","title":{"rendered":"Kaufpreiseinbehalte beim Exit: \u201cEarn out\u201d oder \u201ctake the money and run\u201d?"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">K\u00f6nnen Investoren und Gr\u00fcnder bei einem Exit den gesamten Kaufpreis sofort erhalten und innerhalb m\u00f6glichst kurzer Zeit keinen Gew\u00e4hrleistungsanspr\u00fcchen mehr ausgesetzt sein? Unser Anwalt und Partner Dr. Thomas Derlin gibt in einem Gastbeitrag f\u00fcr die f\u00fcnfte Ausgabe des VentureCapital Magazins einen \u00dcberblick \u00fcber die verschiedenen rechtlichen M\u00f6glichkeiten und notwendigen Vereinbarungen f\u00fcr einen erfolgreichen Exit.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>K\u00f6nnen Investoren und Gr\u00fcnder bei einem Exit den gesamten Kaufpreis sofort erhalten und innerhalb m\u00f6glichst kurzer Zeit keinen Gew\u00e4hrleistungsanspr\u00fcchen mehr ausgesetzt sein? <\/p>\n","protected":false},"author":32,"featured_media":27289,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[282],"tags":[],"ausgabe":[669],"verknuepfung":[725,742],"class_list":["post-35502","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pressespiegel","ausgabe-gsk","verknuepfung-gesellschaftsrecht","verknuepfung-private-equity-venture-capital"],"acf":{"ansprechpartner":[{"anwalt":804}],"postdownloads":[{"download":"https:\/\/gsk.de\/wp-content\/uploads\/2022\/09\/2022-09-16_VC-Magazin_Earn-out-or-take-the-money_Derlin.pdf","anzeigetitel":"Gastbeitrag herunterladen"}]},"info":{"date":"21.09.2022","author":"GSK Sysop","categories_names":["Pressespiegel"],"category":"Pressespiegel"},"wpml_main_post_id":35502,"featured_img_src":"https:\/\/gsk.de\/wp-content\/uploads\/2021\/08\/Derlin_Thomas_1985x1280px-1024x660.jpg","_links":{"self":[{"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/posts\/35502","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/comments?post=35502"}],"version-history":[{"count":0,"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/posts\/35502\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/media\/27289"}],"wp:attachment":[{"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/media?parent=35502"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/categories?post=35502"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/tags?post=35502"},{"taxonomy":"ausgabe","embeddable":true,"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/ausgabe?post=35502"},{"taxonomy":"verknuepfung","embeddable":true,"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/verknuepfung?post=35502"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}